東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Control of Inflammation Using Drug D...

Wardwell, Patricia R.

Linked to FindBook

Google Book

Amazon

博客來

Control of Inflammation Using Drug Delivery Strategies in in vitro Models.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Control of Inflammation Using Drug Delivery Strategies in in vitro Models./
Author:	Wardwell, Patricia R.
Description:	148 p.
Notes:	Source: Dissertation Abstracts International, Volume: 76-11(E), Section: B.
Contained By:	Dissertation Abstracts International76-11B(E).
Subject:	Biomedical engineering. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3713706
ISBN:	9781321903591

Control of Inflammation Using Drug Delivery Strategies in in vitro Models.
Wardwell, Patricia R.

Control of Inflammation Using Drug Delivery Strategies in in vitro Models. - 148 p.

Source: Dissertation Abstracts International, Volume: 76-11(E), Section: B.

Thesis (Ph.D.)--Syracuse University, 2015.

Regulation of inflammation is a crucial component of the immune system in response to injury and infection. In otherwise healthy individuals, an initial acute inflammatory response will subside once the injury or infection is eradicated. However, in certain disease states including autoimmune disease and persistent infection, miscommunication between cells of the immune system leads to a chronic inflammatory response, contributing to disease pathology and exacerbating symptoms. A major regulator of inflammation communication at the cellular level is transcription factor (TF) NF-kappaB. Under normal conditions, NF-kappaB is bound to an inhibitor in the cytoplasm. In a chronic disease state, NF-kappaB is overactive and found in the unbound form, resulting in increased production of inflammatory signals.

ISBN: 9781321903591Subjects--Topical Terms:

535387
Biomedical engineering.

Control of Inflammation Using Drug Delivery Strategies in in vitro Models.
LDR:02967nmm a2200313 4500 001 2064312
005 20151109142633.5
008 170521s2015 ||||||||||||||||| ||eng d
020 $a 9781321903591
035 $a (MiAaPQ)AAI3713706
035 $a AAI3713706
040 $a MiAaPQ $c MiAaPQ
100 1 $a Wardwell, Patricia R. $3 3178881
245 1 0 $a Control of Inflammation Using Drug Delivery Strategies in in vitro Models.
300 $a 148 p.
500 $a Source: Dissertation Abstracts International, Volume: 76-11(E), Section: B.
500 $a Adviser: Rebecca A. Bader.
502 $a Thesis (Ph.D.)--Syracuse University, 2015.
520 $a Regulation of inflammation is a crucial component of the immune system in response to injury and infection. In otherwise healthy individuals, an initial acute inflammatory response will subside once the injury or infection is eradicated. However, in certain disease states including autoimmune disease and persistent infection, miscommunication between cells of the immune system leads to a chronic inflammatory response, contributing to disease pathology and exacerbating symptoms. A major regulator of inflammation communication at the cellular level is transcription factor (TF) NF-kappaB. Under normal conditions, NF-kappaB is bound to an inhibitor in the cytoplasm. In a chronic disease state, NF-kappaB is overactive and found in the unbound form, resulting in increased production of inflammatory signals.
520 $a Transcription factor decoys (TFD) are small nucleic acid sequences (~20 base pairs) that mimic the binding site for the TF on the native DNA, but do not encode for any proteins. By binding to the TF in the cytoplasm, TFD have potential to limit excessive immune signaling and inflammatory protein production. Unfortunately, clinical success of TFD has been hampered by a lack of an effective delivery method. Lack of stability and ease of degradation of the TFD require a protective carrier for delivery; however many synthetic carrier systems induce toxicity or an enhanced inflammatory response. In disease states characterized by excessive inflammation, treatment-induced toxicity or immune response is highly undesirable.
520 $a The Bader lab has previously reported a nanoparticle carrier system based on natural polysaccharides, designed specifically for the treatment of rheumatoid arthritis. The materials used in this system have properties that can be exploited for the additional application of DNA delivery. This thesis will detail the adaptation of polysialic acid-N-trimethyl chitosan nanoparticles to be used as delivery vehicles for an NF-kappaB TFD treatment in in vitro models of rheumatoid arthritis and cystic fibrosis.
590 $a School code: 0659.
650 4 $a Biomedical engineering. $3 535387
650 4 $a Nanoscience. $3 587832
650 4 $a Cellular biology. $3 3172791
690 $a 0541
690 $a 0565
690 $a 0379
710 2 $a Syracuse University. $b Biomedical and Chemical Engineering. $3 1684294
773 0 $t Dissertation Abstracts International $g 76-11B(E).
790 $a 0659
791 $a Ph.D.
792 $a 2015
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3713706